Federal Register / Vol. 65, No. 74 / Monday, April 17, 2000 / Notices 20473

Hyatt Regency Washington on Capitol

Hill, 400 New Jersey Avenue, NW,

Washington, D. C. 20001. The

conference begins at 8:00 a.m. on April

17, 8:00 a.m. on April 18, and 8:30 a.m.

on April 19.

The Office of Research on Minority

Health (ORMH), Office of the Director,

National Institutes of Health (NIH), is

convening this conference. ORMH is a

central leadership entity at the NIH for

issues related to minority health

research and research training. Reports

of progress and accomplishments since

the founding of ORMH in 1990 and

developing a strategic plan for future

actions for eliminating health research

and research training disparities

comprise the agenda of the conference.

Specific conference objectives

include:

• Recommending a framework for the

ORMH to address continuing disparity

in health status of the US population

and the international community

through the Minority Health Strategic

Plan;

• Highlighting the role of the ORMH

to address disparity in health status

through basic and clinical research and

research training in biomedical and

behavioral sciences; and

• Promoting partnerships with

leaders in Congress, associations,

academic institutions, industry,

community-based organizations, and

other Federal agencies to help eliminate

health disparity.

The primary sponsor of this

conference is ORMH. Advance

information on the conference program

and conference registration materials

maybe obtained from Debra Rainey,

LCLM, LLC, Inc., 1299 Lamberton Drive,

Suite 205, Silver Spring, Maryland

20902 (telephone: 301–593–2800).

Dated: April 7, 2000.

Yvonne Maddox,

Acting Deputy Director, National Institutes

of Health.

[FR Doc. 00–9445 Filed 4–14–00; 8:45 am]

BILLING CODE 4140–01–U

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Center for Complementary &

Alternative Medicine; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Cancer Advisory Panel for

Complementary and Alternative

Medicine.

The meeting will be closed to the

public in accordance with the

provisions set forth in section

552b(c)(9)(B), Title 5 U.S.C., as amended

because the premature disclosure of

program documents—PAC and the

discussions would likely to significantly

frustrate implementation of

recommendations.

Name of Committee: Cancer Advisory

Panel for Complementary and Alternative

Medicine.

Date: April 19, 2000.

Time: 2:30 PM to 5:00 PM.

Agenda: To review and evaluate the

Gonzalez Regiment.

Place: National Institutes of Health, 9000

Rockville Pike, Bldg. 31, Room 5B5B,

Bethesda, MD 20892, (Telephone Conference

Call).

Contact Person: Richard Nahin, PhD,

Executive Secretary, Cancer Advisory Panel

for Complementary, and Alternative

Medicine, NCCAM, NIH, 9000 Rockville

Pike, Building 31, Room 5B37, Bethesda, MD

20892, 301–594–2013.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Dated: April 6, 2000.

Anna Snouffer,

Acting Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–9436 Filed 4–14–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 522b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel,

Mentored Clinical Scientist Development

Awards (K08).

Date: April 12, 2000.

Time: 2:30 PM to 4 PM.

Agenda: To review and evaluate grant

applications.

Place: 6701 Rockledge Drive, Room 7214,

Bethesda, MD 20892 (Telephone Conference

Call).

Contact Person: C. James Scheirer, PhD,

Chief, Review Branch, Division of Extramural

Affairs, National Heart, Lung, and Blood

Institute, Rockledge Center II, 6701

Rockledge Drive, Suite 7216, Bethesda, MD

20892–7924, 301–435–0266.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Disease Research; 93.839, Blood Diseases and

Resources Research, National Institutes of

Health, HHS)

Dated: April 6, 2000.

Anna Snouffer,

Acting Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–9434 Filed 4–14–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications

and/or contract proposals and the

discussions could disclose confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the grant

applications and/or contract proposals,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel

Fluorescent Indicator Dyes for Extracellular

Ions (SBIR).

Date: May 4, 2000.

Time: 9:00 AM to 11:00 AM.

Agenda: To review and evaluate contract

proposals.

Place: 6701 Rockledge Drive, Room 4212,

Bethesda, MD 20817 (Telephone Conference

Call).